Anika Therapeutics, Inc. (ANIK): Shareholders' Equity
$143.47M
As of 2025-12-31
$137.28M
As of 2026-06-30
-20.5%
3-year compound annual growth
-12.0%
5-year compound annual growth
-3.8%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $143.47M | -6.8% | 2026-03-03, Balance as of period end |
| 2024-12-31 | $153.99M | -27.5% | 2026-03-03, Balance as of period end |
| 2023-12-31 | $212.26M | -25.7% | 2026-03-03, Balance as of period end |
| 2022-12-31 | $285.56M | -0.5% | 2025-03-17, Balance as of period end |
| 2021-12-31 | $287.08M | +5.4% | 2024-03-15, Balance as of period end |
| 2020-12-31 | $272.40M | -5.5% | 2023-03-16, Balance as of period end |
| 2019-12-31 | $288.38M | +9.4% | 2022-03-11, Balance as of period end |
| 2018-12-31 | $263.61M | 0.0% | 2021-04-26, Balance as of period end |
| 2017-12-31 | $263.49M | +18.3% | 2020-03-06, Balance as of period end |
| 2016-12-31 | $222.77M | +5.7% | 2019-02-27, Balance as of period end |
| 2015-12-31 | $210.85M | +18.4% | 2018-02-27, Balance as of period end |
| 2014-12-31 | $178.10M | +31.3% | 2017-02-24, Balance as of period end |
| 2013-12-31 | $135.63M | +24.5% | 2016-03-10, Balance as of period end |
| 2012-12-31 | $108.93M | +14.9% | 2015-03-13, Balance as of period end |
| 2011-12-31 | $94.76M | +11.2% | 2014-03-13, Balance as of period end |
| 2010-12-31 | $85.19M | +3.7% | 2013-03-14, Balance as of period end |
| 2009-12-31 | $82.14M | n/a | 2012-03-13, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $143.47M | -6.8% |
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $340.83M | -16.9% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $287.61M | n/m |
| NeuroPace Inc (NPCE) | 2025-12-31 | $19.03M | +137.5% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $259.66M | +26.4% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $50.95M | +18.6% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $54.12M | -36.9% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $57.33M | -0.4% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $22.38M | -19.2% |
Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗